Additional information Certificate of Analysis Every batch undergoes independent third-party laboratory analysis to verify identity, potency, and safety
BPC 157 has not been approved for human therapeutic use by major regulatory bodies like the FDA or the U.S
Research Database Browse peer-reviewed studies, clinical trials, and scientific sources behind our peptide resources.
Factors affecting individual response Response to AHK-Cu varies substantially between individuals
Some possible peptide therapy side effects include: Hives, swelling, or breathing difficulty High blood pressure, rapid heart rate, and palpitations Nausea, vomiting, and diarrhea Headaches and dizziness Rashes Always consult a doctor before starting peptide therapy